Annual report pursuant to Section 13 and 15(d)

Acquisitions - Preliminary and Final Fair Value of Assets and Liabilities Assumed (Details)

v3.22.2.2
Acquisitions - Preliminary and Final Fair Value of Assets and Liabilities Assumed (Details) - USD ($)
$ in Thousands
12 Months Ended
Apr. 06, 2021
Oct. 20, 2020
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2020
Goodwill     $ 843,067 $ 822,101 $ 728,310
Payments to Acquire Businesses, Net of Cash Acquired, Total     225,352    
Changzhou Eminence Biotechnology [Member]          
Current assets, net of cash     3,145    
Equipment and other long-term assets     1,639    
Goodwill     7,848    
Total assets acquired     21,543    
Liabilities     1,436    
Deferred income taxes, net     1,357    
Net assets acquired     18,750    
Payments to Acquire Businesses, Net of Cash Acquired, Total   $ 9,800 9,765    
Contingent consideration payable     8,985    
Fair value of noncontrolling interest in Eminence   $ 9,000      
Net assets acquired     18,750    
Changzhou Eminence Biotechnology [Member] | Developed Technology Rights [Member]          
Intangible assets     6,778    
Changzhou Eminence Biotechnology [Member] | Customer Relationships [Member]          
Intangible assets     2,133    
Acquisition of Asuragen, Inc. [Member]          
Current assets, net of cash     10,422    
Equipment and other long-term assets     3,762    
Goodwill     90,563    
Total assets acquired     249,147    
Liabilities     4,963    
Deferred income taxes, net     10,297    
Net assets acquired     233,887    
Payments to Acquire Businesses, Net of Cash Acquired, Total $ 216,000   215,587    
Contingent consideration payable     18,300    
Net assets acquired     233,887    
Acquisition of Asuragen, Inc. [Member] | In Process Research and Development [Member]          
In-process research and development     22,700    
Acquisition of Asuragen, Inc. [Member] | Developed Technology Rights [Member]          
Intangible assets     107,000    
Acquisition of Asuragen, Inc. [Member] | Customer Relationships [Member]          
Intangible assets     11,700    
Acquisition of Asuragen, Inc. [Member] | Trade Names [Member]          
Intangible assets     2,000    
Acquisition of Asuragen, Inc. [Member] | Noncompete Agreements [Member]          
Intangible assets     $ 1,000